209 related articles for article (PubMed ID: 11299767)
1. Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro.
Milligan SA; Nopajaroonsri C
Anticancer Res; 2001; 21(1A):39-44. PubMed ID: 11299767
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-proteasome inhibition enhances apoptosis of human pancreatic cancer cells.
McDade TP; Perugini RA; Vittimberga FJ; Callery MP
Surgery; 1999 Aug; 126(2):371-7. PubMed ID: 10455908
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
Sakai T; Kambe F; Mitsuyama H; Ishiguro N; Kurokouchi K; Takigawa M; Iwata H; Seo H
J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
[TBL] [Abstract][Full Text] [Related]
4. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation.
Watanabe K; Kubota M; Hamahata K; Lin Y; Usami I
Biochem Pharmacol; 2000 Sep; 60(6):823-30. PubMed ID: 10930537
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-proteasome inhibitor enhances tumour necrosis factor-alpha-induced apoptosis in rat gastric epithelial cells.
Naito Y; Handa O; Takagi T; Ishikawa T; Imamoto E; Nakagawa S; Yamaguchi T; Yoshida N; Matsui H; Yoshikawa T
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():59-66. PubMed ID: 11966525
[TBL] [Abstract][Full Text] [Related]
6. Effect of NF-kappa B Inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes.
Bergmann MW; Loser P; Dietz R; von Harsdorf R
J Mol Cell Cardiol; 2001 Jun; 33(6):1223-32. PubMed ID: 11444925
[TBL] [Abstract][Full Text] [Related]
7. NF-kappaB activation is related to the resistance of lung cancer cells to TNF-alpha-induced apoptosis.
Kim JY; Lee S; Hwangbo B; Lee CT; Kim YW; Han SK; Shim YS; Yoo CG
Biochem Biophys Res Commun; 2000 Jun; 273(1):140-6. PubMed ID: 10873576
[TBL] [Abstract][Full Text] [Related]
8. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.
Manna SK; Aggarwal BB
J Immunol; 1998 Sep; 161(6):2863-72. PubMed ID: 9743347
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells.
Németh ZH; Wong HR; Odoms K; Deitch EA; Szabó C; Vizi ES; Haskó G
Mol Pharmacol; 2004 Feb; 65(2):342-9. PubMed ID: 14742676
[TBL] [Abstract][Full Text] [Related]
10. Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells.
McDade TP; Perugini RA; Vittimberga FJ; Carrigan RC; Callery MP
J Surg Res; 1999 May; 83(1):56-61. PubMed ID: 10210643
[TBL] [Abstract][Full Text] [Related]
11. Activation of NF-kappa B by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites.
Sun SC; Maggirwar SB; Harhaj E
J Biol Chem; 1995 Aug; 270(31):18347-51. PubMed ID: 7629157
[TBL] [Abstract][Full Text] [Related]
12. Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.
Sunwoo JB; Chen Z; Dong G; Yeh N; Crowl Bancroft C; Sausville E; Adams J; Elliott P; Van Waes C
Clin Cancer Res; 2001 May; 7(5):1419-28. PubMed ID: 11350913
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132.
Fiedler MA; Wernke-Dollries K; Stark JM
Am J Respir Cell Mol Biol; 1998 Aug; 19(2):259-68. PubMed ID: 9698598
[TBL] [Abstract][Full Text] [Related]
14. Proteasome regulation of Fas ligand cytotoxicity.
Matsui K; Omura S; Cui H; Schauer SL; Sonenshein GE; Ju ST
Eur J Immunol; 1997 Sep; 27(9):2269-78. PubMed ID: 9341769
[TBL] [Abstract][Full Text] [Related]
15. The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis.
Delic J; Masdehors P; Omura S; Cosset JM; Dumont J; Binet JL; Magdelénat H
Br J Cancer; 1998 Apr; 77(7):1103-7. PubMed ID: 9569046
[TBL] [Abstract][Full Text] [Related]
16. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
[TBL] [Abstract][Full Text] [Related]
17. Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer.
Denlinger CE; Keller MD; Mayo MW; Broad RM; Jones DR
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1078-86. PubMed ID: 15052205
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation.
Prösch S; Priemer C; Höflich C; Liebenthaf C; Babel N; Krüger DH; Volk HD
Antivir Ther; 2003 Dec; 8(6):555-67. PubMed ID: 14760889
[TBL] [Abstract][Full Text] [Related]
19. The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells.
Giuliano M; Lauricella M; Calvaruso G; Carabillò M; Emanuele S; Vento R; Tesoriere G
Cancer Res; 1999 Nov; 59(21):5586-95. PubMed ID: 10554039
[TBL] [Abstract][Full Text] [Related]
20. IFNalpha sensitizes ME-180 human cervical cancer cells to TNFalpha-induced apoptosis by inhibiting cytoprotective NF-kappaB activation.
Suk K; Kim YH; Chang I; Kim JY; Choi YH; Lee KY; Lee MS
FEBS Lett; 2001 Apr; 495(1-2):66-70. PubMed ID: 11322949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
